Brief: Cereno Scientific Submits Application For Start Of Clinical Phase II Study To Bulgarian Authorities

Cereno Scientific AB

31/05/2019 10:39

May 31 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC SUBMITS APPLICATION FOR THE START OF
CLINICAL
PHASE II STUDY TO BULGARIAN AUTHORITIES
    * AIM OF PHASE II STUDY IS TO SHOW DRUG CANDIDATE CS1'S
PREVENTIVE
EFFECT AGAINST FORMATION OF BLOOD CLOTS AFTER SURGERY
    * STUDY WILL BE CONDUCTED AT APPROXIMATELY 30 CLINICS IN
RUSSIA
AND BULGARIA
    * WE LOOK FORWARD TO OBTAINING APPROVAL OF SAID AUTHORITIES
DURING
FALL THIS YEAR AND SUBSEQUENTLY TO INITIATE STUDY, WHICH IS
EXPECTED TO TAKE PLACE DURING FIRST HALF OF 2020 - CEO

Source text for Eikon:  ID:nWkr1vjLXQ 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))